ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,894, issued on Sept. 23, was assigned to Novartis AG (Basel, Switzerland).
"Ribociclib tablet" was invented by Rui Costa (Basel, Switzerland), Arnaud Grandeury (Helfrantzkirch, France) and Bindhumadhavan Gururajan (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to oral tablet of ribociclib including its salt(s). One embodiment of the present disclosure is directed to tablet of ribociclib with high drug load with an immediate release profile. One embodiment of the present disclosure is directed to coated tablet of ribociclib. Another embodiment of the present disclosure is directed to coated tabl...